Notwithstanding anything to the contrary set forth in [Article 5] of the Bellus License Agreement, FB Health may disclose Confidential Information of Bellus to ​, provided that such disclosure complies with the requirements of [Section 5.2] of the Bellus License Agreement. The parties hereto recognize that, from time to time, ​ might receive from Bellus or FB Health Confidential Information of Bellus (or other information that would have constituted Confidential Information of Bellus under the Bellus License Agreement if it had been disclosed by Bellus to FB Health) (collectively, “Bellus Information”). The parties hereto agree that the terms and conditions of [Article 5] of the ​ Sublicense Agreement that apply to Confidential Information of FB Health shall also apply to such Bellus Information, except that references in [Article 5] to the “other Party” with respect to such Bellus Information shall be deemed to refer to Bellus, not FB Health.

Notwithstanding anything to the contrary set forth in [Article 5] of the Bellus License​ Sublicense Agreement, FB Health may disclose Confidential Information of Bellus​ to ​,Bellus, provided that such disclosure complies with the requirements of [Section 5.2] of the Bellus License​ Sublicense Agreement. The parties hereto recognize that, from time to time, ​Bellus might receive from Bellus​ or FB Health Confidential Information of Bellus​ (or other information that would have constituted Confidential Information of Bellus​ under the Bellus License​ Sublicense Agreement if it had been disclosed by Bellus​ to FB Health) (collectively, “Bellus Information”). The parties hereto agree that the terms and conditions of [Article 5] of the _Organization“​ Sublicense Agreement that apply to Confidential Information of FB Health shall also apply to such Bellus Information, except that references in [Article 5] to the “other Party” with respect to such Bellus Information shall be deemed to refer to Bellus, not FB Health.

Information”). The parties hereto agree that the terms and conditions of [Article 5] of the ​ SublicenseBellus License Agreement that apply to Confidential Information of FB Health shall also apply to such Bellus​ Information, except that references in [Article 5] to the “other Party” with respect to such Bellus​ Information shall be deemed to refer to Bellus,​, not FB Health.

As you are aware, pursuant to the contrary set forth in [Article 5]Bellus License Agreement, Bellus has licensed to FB Health certain Patent Rights and Know-How owned or Controlled by Bellus and has granted to FB Health certain rights related thereto. As contemplated by [Section 2.3] of the Bellus License Agreement, simultaneously with the execution of this letter agreement (this “Letter Agreement”), FB Health may disclose Confidential Information of Bellusis entering into an agreement with ​ pursuant to which FB Health is sublicensing to organization" data-ad-field-json='{"name":"Organization B","type":"organization","canGuess":{"name":false,"type":false}}'>​, providedOrganization_ all of the rights licensed or otherwise granted to FB Health by ​ under the Bellus License Agreement, subject to certain rights retained by FB Health with respect to Italy (the “​ Sublicense Agreement”). The ​ Sublicense Agreement is attached hereto as [Exhibit A]. By executing this Letter Agreement, Bellus hereby acknowledges that such disclosure compliesFB Health is granting a sublicense of its rights under the Bellus Agreement to ​ in accordance with the requirements of [Section 5.2]2.3] of the Bellus License Agreement. The parties hereto recognize that, from timeAgreement and consents to time, ​ might receive from Bellus or FB Health Confidential Informationsuch sublicense and other assignment of Bellus (or other information that would have constituted Confidential Information of Bellus under the Bellus License Agreement if it had been disclosed by Bellus to FB Health) (collectively, “Bellus Information”). The parties hereto agree that the terms and conditions of [Article 5] ofrights granted in the ​ Sublicense Agreement that apply to Confidential Information of FB Health shall also apply to such Bellus Information, except that references in [Article 5] to the “other Party” with respect to such Bellus Information shall be deemed to refer to Bellus, not FB Health.Agreement.